Tudor Investment Corp’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Tudor Investment Corp's ANAB Position: Q2 2026 in Review
Tudor Investment Corp increased its AnaptysBio (ANAB) stake by 303% in Q2 2026, buying an estimated $913K and bringing the position to 20,019 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2205.
Tudor Investment Corp first reported a position in ANAB in Q3 2019 and has held it in 15 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Tudor Investment Corp held 20,019 shares of AnaptysBio worth $1.35M as of Q2 2026.
- Tudor Investment Corp bought 15,057 AnaptysBio shares in Q2 2026, an estimated $913K.
- AnaptysBio made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #2205 holding.
- Tudor Investment Corp first reported a position in AnaptysBio in Q3 2019 and has held it in 15 quarters since.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.